RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Readout Capital
R

Readout Capital portfolio

Readout Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $90M.
Latest deal: Epicrispr Biotechnologies · Aug 11, 2026.
About this page

Its most recent investment on record is Epicrispr Biotechnologies's $90M Series B+ round in August 2026, alongside Janus Henderson Investors, Duquesne Family Office, Octagon Capital Advisors and 5 others. That company is in Health and bio.

What Readout Capital invests in

How Readout Capital invests

StageDealsCapital in rounds
Series B+ 1 100%$90M

Readout Capital portfolio companies

CompanyRound with Readout CapitalTotal raisedLatest raise
EEpicrispr Biotechnologies
Health and bio
 Series B+ · $90M$158MAug 11, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Readout Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Readout Capital, which is a subset of its real portfolio. API: /api/v1/investors/readout-capital (get a free API key). More: the most active VC firms and new venture capital funds.